Trans-national Access (TA) ensures free-of-charge access to the services and expertise of the EurOPDX Research Infrastructure.
As partners of canSERV, which is aimed to provide cutting-edge cancer research services across Europe (grant agreement 101058620), this opportunity is available since 2023.
If you wish to apply, please consider that the application process must be done through the ARIA system.
Reference contact: gorettimallorqui@vhio.net
As partners in canSERV, TA is provided by a distributed infrastructure composed of four independent nodes, which are state-of-the-art laboratories or platforms performing research using PDX models:
SERVICES PROVIDED by IC, NKI, UniTo and VHIO
More info +
SERVICES PROVIDED by IC
Shipment of a frozen PDX sample to academic laboratories
Biobanking at the EurOPDX infrastructure of a user-supplied PDX model
In vivo drug efficacy testing on a selected PDX model
Molecular profiling of a PDX model
SERVICES PROVIDED by NKI
Shipment of a frozen PDX sample to academic laboratories
Biobanking at the EurOPDX infrastructure of a user-supplied PDX model
In vivo drug efficacy testing on a selected PDX model
Molecular profiling of a PDX modelIn-depth cancer-based phenotyping of cancer mouse models
Cancer Path Builder, a service to help users navigate the canSERV catalogue and elaborate complex projects involving multiple services
SERVICES PROVIDED by UniTo
Shipment of a frozen PDX sample to academic laboratories
Biobanking at the EurOPDX infrastructure of a user-supplied PDX model
In vivo drug efficacy testing on a selected PDX model
Molecular profiling (NGS, IHC. IF) of a PDX model
SERVICES PROVIDED by VHIO
Shipment of a frozen PDX sample to academic laboratories
Biobanking at the EurOPDX node VHIO of a user-supplied PDX model
In vivo preclinical validation of response predictors (biomarkers)
To browse our available models, visit CancerModels.org